CONSOLIDATED STATEMENTS OF CASH FLOWS $ in Millions, $ in Millions		12 Months Ended
		Dec. 31, 2024 CAD ($)		Dec. 31, 2023 CAD ($)		Dec. 31, 2022 CAD ($)
Operating activities
Earnings		$ 5,631		$ 6,058		$ 2,938
Adjustments to reconcile earnings to net cash provided by operating activities:
Depreciation and amortization		5,167		4,613		4,317
Deferred income tax expense (Note 24)		719		1,420		957
Unrealized derivative fair value (gain)/loss, net (Note 23)		2,082		(1,180)		1,280
Income from equity investments (Note 13)		(2,304)		(1,816)		(2,056)
Distributions from equity investments		2,121		1,998		1,827
Impairment of long-lived assets		190		419		541
Impairment of goodwill		0		0		2,465
Gain on joint venture merger transaction (Note 13)		0		0		(1,076)
Gain on disposition of equity investment		(1,091)		0		0
Other		218		378		49
Changes in operating assets and liabilities (Note 28)		(133)		2,311		(12)
Net cash provided by operating activities		12,600		14,201		11,230
Investing activities
Capital expenditures		(6,711)		(4,654)		(4,647)
Long-term, restricted and other investments		(3,416)		(1,276)		(1,041)
Distributions from equity investments in excess of cumulative earnings		785		1,151		763
Additions to intangible assets		(219)		(222)		(174)
Acquisitions		(13,472)		(954)		(828)
Proceeds from joint venture merger transaction (Note 13)		0		0		522
Proceeds from dispositions of equity investments		2,724		0		0
Net change in affiliate loans		2		(27)		135
Other		(56)		(61)		0
Net cash used in investing activities		(20,363)		(6,043)		(5,270)
Financing activities
Net change in short-term borrowings		129		(1,596)		481
Net change in commercial paper and credit facility draws		6,549		(8,157)		(1,333)
Debenture and term note issues, net of issue costs		9,546		15,377		7,547
Debenture and term note repayments		(6,633)		(4,819)		(4,198)
Sale of noncontrolling interest in subsidiary (Note 8)		0		0		1,092
Contributions from noncontrolling interests		4		11		13
Distributions to noncontrolling interests		(333)		(363)		(259)
Common shares issued, net of issue costs		2,485		4,450		3
Common shares repurchased		0		(125)		(151)
Preference share dividends		(387)		(352)		(338)
Common share dividends		(7,875)		(7,276)		(6,968)
Redemption of preference shares		0		0		(1,003)
Net change in affiliate loan		99		71		0
Other		(40)		(85)		(314)
Net cash provided by/(used in) financing activities		3,544		(2,864)		(5,428)
Effect of translation of foreign denominated cash and cash equivalents and restricted cash		234		(216)		55
Net change in cash and cash equivalents and restricted cash		(3,985)		5,078		587
Cash and cash equivalents and restricted cash at beginning of year		5,985	[1]	907	[1]	320
Cash and cash equivalents and restricted cash at end of year1	[1]	2,000		5,985		907
Supplementary cash flow information
Cash paid for income taxes		861		578		495
Cash paid for interest, net of amount capitalized		4,134		3,380		2,920
Property, plant and equipment and intangible assets non-cash accruals		$ 1,251		$ 813		$ 937

[1] 1 As at December 31, 2024, long-term restricted cash of $105 million (2023 and 2022 - nil) was included in Restricted long-term investments and cash in the Consolidated Statements of Financial Position.